Saturday, October 23, 2021

FDA approves first commercially available booster shot to protect against measles, mumps and rubella | Newsroom

Must read

Overview

The Food and Drug Administration (FDA) approved the first commercially available multi-dose, or booster, vaccine, Booster Shot for Vulnerable Populations. Booster Shot contains chickenpox and MMR (measles, mumps, rubella), which will protect nearly 400,000 infants and older people over five years from serious disease and death from those diseases if used as a booster.

In November 2016, the National Institutes of Health issued guidelines to those caring for a baby who is being cared for in the neonatal intensive care unit (NICU) or who is undergoing an intensive therapy.

Dr. Seth Berkowitz, a co-author of the paper, describes the sticker-label as a safety indicator placed on each bottle with the vaccine. When a baby is born, doctors need to protect it from infection with these diseases. Booster Shots will protect infants and others up to five years old from those diseases. Booster Shots are designed to prevent serious diseases, particularly of infants. They cannot prevent all these illnesses, but given to people who are at high risk, they offer potentially significant benefits to those who need protection.

“The new booster vaccine will not prevent a certain amount of disease in each patient, but will provide a significant protective effect against serious diseases,” Berkowitz said. Booster Shots are being approved on three labels, a new label for those likely to encounter vaccination-preventable illness while in the hospital, a shorter label that illustrates how to use the vaccine to protect children and adults, and a long label for older people who may also encounter vaccine-preventable illnesses.

Breastfeeding Women

Breastfeeding provides immediate protection from measles, mumps, rubella and chickenpox. Booster Shots for Vulnerable Populations is intended to be given to babies less than six months old, preteens older than 14, and high-risk adults, including healthcare workers, and people caring for infants under the age of three months.

The FDA approved Booster Shots for Vulnerable Populations based on clinical trials on adults, children and babies and analyses of the vaccine data. Booster Shots can prevent two preventable diseases. Two doctors have presented preliminary findings of clinical trials that provide evidence that Booster Shots are protective against measles, mumps, rubella and chickenpox. Booster Shots may be administered to children and adults, and Booster Shots are available over the counter at most drugstores. Booster Shots are most effective in children younger than seven and for adults between 18 and 44. For those adults to get this vaccine they must be at high risk of infection and that means a health professional.

The safety information for this vaccine will have to be kept updated with scientific evidence. Booster Shots is only available as a 3g product.

Media Inquiries

Kristin Riley, 301-796-2534, [email protected]

Consumer Inquiries

Angela Clark, 301-796-3542, [email protected]

More articles

Latest article